| 股號 / 名稱 | 營收 | 稅後淨利 |
| NVO 諾和諾德 | 372,999,583,673.24 | 99,528,244,651.18 |
| ABT 美國雅培 | 359,521,120,729.4 | 51,988,101,194.4 |
| MDT 美敦力 | 283,373,099,028.6 | 43,702,892,853.2 |
| SYK 史賽克 | 191,540,102,758.2 | 27,164,099,103.4 |
| BSX Boston Scientific Corp | 160,170,153,619.0 | 23,906,937,045.6 |
| PHG Koninklijke Philips NV | 159,656,001,417.53 | 6,977,063,753.25 |
| ZBH Zimmer Biomet Holdings Inc | 63,290,137,305.64 | 7,311,222,017.12 |
| RMD 瑞思邁 | 42,235,019,567.77 | 11,021,730,436.67 |
| QDEL QuidelOrtho Corp | 22,132,890,526.74 | -23,179,609,595.8 |
| NVST Envista Holdings Corp | 21,184,202,548.74 | -958,174,857.78 |
| BIO Bio Rad Laboratories Inc | 20,649,774,987.8 | -10,811,880,655.94 |
| BRBR Bellring Brands Inc | 20,497,984,911.32 | 1,884,726,782.96 |
| ICUI ICU Medical Inc | 16,981,198,576.87 | -58,660,539.97 |
| EYE National Vision Holdings Inc | 15,410,803,743.96 | 106,632,528.73 |
| PAHC Phibro Animal Health Corp | 11,507,363,812.61 | 838,861,533.08 |
| NEOG Neogen Corp | 7,105,388,348.83 | -503,563,578.72 |
| WRBY Warby Parker Inc | 7,010,171,698.77 | 185,753,106.09 |
| TGTX TG Therapeutics Inc | 5,113,712,807.81 | 12,361,246,238.68 |
| ATRC AtriCure Inc | 4,245,979,537.27 | -8,443,323.0 |
| INMD Inmode Ltd | 2,946,150,515.68 | 691,372,175.43 |
| MGNX MacroGenics Inc | 2,303,382,787.65 | 531,960,972.2 |
| VMD Viemed Healthcare Inc | 2,274,131,575.0 | 113,842,557.36 |
| EOLS Evolus Inc | 2,180,938,792.62 | -497,650,090.33 |
| CERS Cerus Corp | 1,904,870,591.03 | -632,458.65 |
| MRVI Maravai LifeSciences Holdings Inc | 1,316,462,684.14 | -1,424,834,474.16 |
| ZVIA Zevia PBC | 1,291,607,059.11 | -90,062,112.04 |
| QTRX Quanterix Corp | 1,272,285,447.3 | -1,059,905,831.95 |
| INFU InfuSystem Holdings Inc | 1,153,857,564.71 | 71,436,204.74 |
| VALN Valneva SE | 1,091,428,020.85 | -1,646,104,589.23 |
| BLFS BioLife Solutions Inc | 887,560,849.28 | 19,637,841.14 |
| XGN Exagen Inc | 545,305,849.75 | -224,111,723.34 |
| RMTI Rockwell Medical Inc | 503,658,447.52 | -55,435,000.85 |
| APYX Apyx Medical Inc | 407,208,503.09 | -61,822,833.23 |
| MYO Myomo Inc | 319,097,525.99 | -115,832,272.28 |
| IMCC IM Cannabis Corp | 314,775,339.93 | -87,835,296.28 |
| UTMD Utah Medical Products Inc | 310,284,214.67 | 83,199,935.67 |
| FLGC Flora Growth Corp | 308,260,346.98 | -114,696,376.54 |
| CTSO Cytosorbents Corp | 299,943,515.71 | -100,244,696.34 |
| ICCC ImmuCell Corp | 174,119,661.65 | -4,419,304.83 |
| NEPH Nephros Inc | 150,651,650.91 | 10,656,928.29 |
| UG United-Guardian Inc | 71,602,541.37 | 8,488,860.03 |
| SNES Senestech Inc | 21,819,823.49 | -41,046,566.51 |
| GCTK GlucoTrack Inc | 0.0 | -131,899,251.87 |
| PHGE Biomx Inc | 0.0 | -289,855,800.21 |
| OMER Omeros Corp | 0.0 | -671,765,957.22 |
| VERU Veru Inc | 0.0 | 41,240,731.32 |
| CLRB Cellectar Biosciences Inc | 0.0 | -140,528,517.72 |
| CAPR Capricor Therapeutics Inc | 0.0 | -776,996,008.89 |
| ORMP Oramed Pharmaceuticals Inc | 0.0 | 1,530,202,085.58 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股營收排名、龍頭是誰？
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例